High Falls Advisors, Inc Pfizer Inc Transaction History

High Falls Advisors, Inc

$425 Million
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $8,862 - $11,538	-225 Reduced 3.84%	5,632 $229,000
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $83,166 - $108,564	-1,992 Reduced 25.38%	5,857 $300,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $437 - $534	10 Added 0.13%	7,849 $343,000
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $12,749 - $15,116	-274 Reduced 3.38%	7,839 $411,000
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $457 - $566	10 Added 0.12%	8,113 $420,000
Q4 2021 Feb 15, 2022	BUY	$41.32 - $61.25 $1,198 - $1,776	29 Added 0.36%	8,103 $479,000
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $43,842 - $56,319	-1,117 Reduced 12.15%	8,074 $347,000
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $7,361 - $8,339	-205 Reduced 2.18%	9,191 $360,000
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $837 - $944	25 Added 0.27%	9,396 $340,000
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $313,647 - $398,829	9,371 New	9,371 $344,000
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $293,020 - $343,780	-9,229 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $662 - $803	22 Added 0.24%	9,229 $302,000
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $7,622 - $10,890	-282 Reduced 2.97%	9,207 $301,000
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $2,534 - $2,876	-77 Reduced 0.8%	9,489 $372,000
Q3 2019 Nov 21, 2019	BUY	$32.49 - $42.13 $129 - $168	4 Added 0.04%	9,566 $344,000
Q2 2019 Aug 15, 2019	BUY	$36.98 - $41.52 $1,220 - $1,370	33 Added 0.35%	9,562 $414,000
Q1 2019 May 16, 2019	BUY	$37.5 - $41.2 $600 - $659	16 Added 0.17%	9,529 $405,000
Q4 2018 Feb 15, 2019	SELL	$38.47 - $43.86 $8,232 - $9,386	-214 Reduced 2.2%	9,513 $415,000
Q3 2018 Nov 16, 2018	BUY	$34.47 - $41.81 $585 - $710	17 Added 0.18%	9,727 $429,000
Q2 2018 Aug 15, 2018	BUY	$32.98 - $35.16 $593 - $632	18 Added 0.19%	9,710 $352,000
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $12,317 - $14,289	-386 Reduced 3.83%	9,692 $344,000
Q4 2017 Feb 16, 2018	SELL	$33.26 - $35.29 $2,561 - $2,717	-77 Reduced 0.76%	10,078 $365,000
Q3 2017 Nov 15, 2017	BUY	$31.0 - $34.15 $314,805 - $346,793	10,155	10,155 $363,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.7 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.3 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.71 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.35 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.46 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Falls Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on High Falls Advisors, Inc with notifications on news.

Account